RECORD // Company
ProPhase Labs, Inc.
Formerly: QUIGLEY CORP
Built 2026-11-22T04:04:47Z from public sources · JSON · Open the company profile
ASK THE RECORDS
Ask
COMPANY
Records for this company (1 joined by official identifier)
Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.
SEC EDGAR (1)
- ProPhase Labs, Inc. · the SEC registrant record of this company
Records under a former name (5)
The name on these records was this company's name in the past (SEC name history). An old name can also belong to an unrelated organization, so they are shown apart and are not counted above.
- QUIGLEY COMPANY INC. · Ct business
- QUIGLEY · Epa echo
- QUIGLEY CO INC · Epa echo
- QUIGLEY COMPANY INC · Epa echo
- QUIGLEY COMPANY, INC. · Ny corps
Matched by name only, not merged (2)
These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).
- PROPHASE LABS INC · East spend · same registered legal name as 'ProPhase Labs, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
- PROPHASE LABS, INC. · Ny corps · same registered legal name as 'ProPhase Labs, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
6 VALUES · 10-Q · EACH LINKS TO ITS FILING
Latest quarter
Latest report: 10-Q for the period ended 2026-06-30, filed 2026-08-19 · accession 0001493152-26-039224
| Item | Value | Period | Form | Filed | Accession | Report | |
|---|---|---|---|---|---|---|---|
| Revenue | $1,011,000 | 3 months ended 2026-06-30 | 10-Q | 2026-08-19 | 0001493152-26-039224 | 2026-11-22 04:04 UTC | Report an error |
| Net income (loss) | $-3,051,000 | 3 months ended 2026-06-30 | 10-Q | 2026-08-19 | 0001493152-26-039224 | 2026-11-22 04:04 UTC | Report an error |
| Interest expense | $791,000 | 3 months ended 2026-06-30 | 10-Q | 2026-08-19 | 0001493152-26-039224 | 2026-11-22 04:04 UTC | Report an error |
| Cash and cash equivalents | $20,000 | at 2026-06-30 | 10-Q | 2026-08-19 | 0001493152-26-039224 | 2026-11-22 04:04 UTC | Report an error |
| Contract liabilities, current | $1,438,000 | at 2026-06-30 | 10-Q | 2026-08-19 | 0001493152-26-039224 | 2026-11-22 04:04 UTC | Report an error |
| Contract liabilities, noncurrent | $348,000 | at 2026-06-30 | 10-Q | 2026-08-19 | 0001493152-26-039224 | 2026-11-22 04:04 UTC | Report an error |
Negative as reported in the filing.
Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.
IDS
Identifiers
- SEC CIK
- 0000868278
- Ticker
- PRPH
- EIN
- 232577138
- CUSIP
- 74345W108
- Record ID
- sx:sec:0000868278
OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA
Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
20 FACTS · EACH LINKS TO ITS FILING
Facts
| Fact | Value | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 04:04 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 04:04 UTC | Report an error |
| State of incorporation | DE | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 04:04 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 04:04 UTC | Report an error |
| Business address | 711 STEWART AVE, SUITE 200, GARDEN CITY, NEW YORK, NY, 11530 | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 04:04 UTC | Report an error |
| Exchanges | OTC | 2026-11-16 | SEC EDGAR company profile | 2026-11-22 04:04 UTC | Report an error |
| Revenue (fiscal year ended 2025-12-31) | $4,345,000 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | 2026-11-22 04:04 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $-14,743,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | 2026-11-22 04:04 UTC | Report an error |
| Total assets (at 2025-12-31) | $59,871,000 | 2025-12-31 | 10-K, XBRL Assets | 2026-11-22 04:04 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $3,508,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | 2026-11-22 04:04 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $90,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | 2026-11-22 04:04 UTC | Report an error |
| Operating cash flow (fiscal year ended 2025-12-31) | $-8,344,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | 2026-11-22 04:04 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $0 | 2025-12-31 | 10-K, XBRL PaymentsToAcquireProductiveAssets | 2026-11-22 04:04 UTC | Report an error |
| Remaining performance obligation (at 2025-12-31) | $2,144,000 | 2025-12-31 | 10-K, XBRL RevenueRemainingPerformanceObligation | 2026-11-22 04:04 UTC | Report an error |
| Operating lease liabilities (at 2024-12-31) | $4,976,000 | 2024-12-31 | 10-K, XBRL OperatingLeaseLiability | 2026-11-22 04:04 UTC | Report an error |
| Form D total offering amount (D filed 2025-08-05) | $6,000,000 | 2025-08-05 | D | 2026-11-22 04:04 UTC | Report an error |
| Form D total amount sold (D filed 2025-08-05) | $3,000,000 | 2025-08-05 | D | 2026-11-22 04:04 UTC | Report an error |
| Form D industry group | Biotechnology | 2025-08-05 | D | 2026-11-22 04:04 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2025-08-05 | D | 2026-11-22 04:04 UTC | Report an error |
| Form D date of first sale | 2025-07-22 | 2025-08-05 | D | 2026-11-22 04:04 UTC | Report an error |
EVERY DATED RECORD, NEWEST FIRST
Timeline
- 2026-11-16 Filing NT 10-Q filed
- 2026-08-19 Filing 10-Q filed
- 2026-08-14 Filing NT 10-Q filed
- 2026-08-06 Filing 8-K filed: Item 1.01 material agreement; Item 2.03 new financial obligation; Item 9.01 exhibits
- 2026-07-09 Filing 10-Q/A filed
- 2026-07-07 Filing 10-Q/A filed
- 2026-06-30 Filing 10-Q filed
- 2026-06-01 Filing 10-K filed
- 2026-05-15 Filing NT 10-Q filed
- 2026-03-27 Filing NT 10-K filed
- 2026-02-13 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-02-13 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-01-27 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-01-23 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-01-23 Filing 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 9.01 exhibits
- 2026-01-23 Filing 25-NSE filed
- 2026-01-09 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2026-01-09 Filing 8-K filed: Item 5.02 officer or director change
- 2026-01-02 Filing 8-K filed: Item 3.01 delisting notice; Item 9.01 exhibits
- 2025-12-29 Filing 424B5 filed
- 2025-12-19 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2025-12-19 Filing 8-K filed: Item 8.01 other event; Item 9.01 exhibits
- 2025-12-19 Filing 424B5 filed
- 2025-12-18 Filing 8-K/A filed: Item 5.03 charter or bylaw amendment; Item 8.01 other event; Item 9.01 exhibits
- 2025-12-12 Filing 8-K/A filed: Item 5.03 charter or bylaw amendment; Item 8.01 other event; Item 9.01 exhibits
WHAT IS NOT HERE
Gaps
- Court records: not covered yet (expected 11-19).
- No H-1B LCA filed under EIN 232577138 in FY2026 Q3
- H-1B LCAs only (H-1B1 and E-3 excluded); one fiscal quarter (FY2026 Q3) only, earlier quarters not loaded
- No Form 5500 plan filed under sponsor EIN 232577138 for plan year 2025
- Plan year 2025 only (EFAST2 'Latest' file); earlier years not loaded
- No Form 990 found for EIN 232577138
- SEC 13F holders: no 13F holdings for this CUSIP in period 2026-06-30
- USAspending: no recipient whose SAM legal name and address match this SEC filer
SOURCES AND LICENSE
Sources
- SEC EDGAR: checked · 2026-11-22T04:04:48Z
- DOL OFLC LCA Disclosure Data: checked, nothing found · 2026-11-22T04:04:49Z
- DOL EBSA Form 5500 public datasets: checked, nothing found · 2026-11-22T04:04:49Z
- Propublica 990: checked, nothing found · 2026-11-22T04:04:49Z
- SEC 13F holdings: checked · 2026-11-22T04:04:50Z
- USAspending: checked, nothing found · 2026-11-22T04:04:51Z
CC BY 4.0 -- credit Seraphix Systems.
API
Use this record
Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.